MedTrace Logo

Circulating Tumor Cells and mpMRI for Non-invasive Diagnosis of Prostate Cancer(CMNDPC)

NCT05947188 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 808

Last updated 2024-02-05

No results posted yet for this study

Summary

This trial is a prospective, multicentre, diagnostic study. This study aims to evaluation the early diagnostic ability of circulating tumor cells plus multimodal MRI for prostate cancer.

Conditions

Interventions

OTHER

prostate cancer diagnosis

prostate cancer diagnosis

Sponsors & Collaborators

  • Tianjin Medical University Second Hospital

    collaborator OTHER

  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    collaborator OTHER

  • Affiliated Hospital of Nantong University

    collaborator OTHER

  • Wujin People's Hospital

    collaborator OTHER

  • Seventh Medical Center of PLA Army General Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Soochow University

    collaborator OTHER

  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • yang gao · First Affiliated Hospital Xi'an Jiaotong University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2024-03-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05947188 on ClinicalTrials.gov